Published in Antimicrob Agents Chemother on May 01, 1985
Antifungal activity of local anesthetics against Candida species. Infect Dis Obstet Gynecol (2000) 0.94
Antifungal activity of nonantifungal drugs. Eur J Clin Microbiol Infect Dis (2003) 0.92
Chlorpromazine as permeabilizer and reagent for detection of microbial peroxidase and peroxidaselike activities. Appl Environ Microbiol (1986) 0.87
Effect of calmodulin inhibitors on viability and mitochondrial potential of Plasmodium falciparum in culture. Antimicrob Agents Chemother (1986) 0.86
Effect of Candida morphology on amphotericin B susceptibility. Antimicrob Agents Chemother (1987) 0.83
Comparative antibacterial activity of Vancocin and generic vancomycin. Antimicrob Agents Chemother (1987) 0.82
A method for testing for synergy with any number of agents. J Infect Dis (1978) 9.52
Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activator of cyclic nucleotide phosphodiesterase. J Pharmacol Exp Ther (1979) 2.15
Zinc and regulation of growth and phenotype in the infectious yeast Candida albicans. Infect Immun (1981) 1.78
Lethal effect of phenothiazine neuroleptics on the pathogenic protozoan Leishmania donovani. Science (1982) 1.30
Chlorpromazine inhibits phagocytosis and exocytosis in rabbit polymorphonuclear leukocytes. Biochem Pharmacol (1979) 1.14
Trifluoperazine inhibits phagocytosis in a macrophagelike cultured cell line. J Cell Biol (1981) 1.06
Decreased viscosity of human erythrocyte suspension induced by chlorpromazine and isoxsuprine. Biochem Pharmacol (1981) 1.02
Evidence for the occurrence of calmodulin in the yeasts Candida albicans and Saccharomyces cerevisiae. FEBS Lett (1982) 1.00
The effect of chlorpromazine on some properties DNA in solution. Physiol Chem Phys (1975) 0.97
Phenothiazine compounds inhibit in vitro growth of pathogenic free-living amoebae. Antimicrob Agents Chemother (1984) 0.95
An ubiquitous protein which regulates calcium-dependent cellular functions and calcium movements. Biochem Pharmacol (1981) 0.93
Distribution of chlorpromazine metabolites in selected organs of psychiatric patients chronically dosed up to the time of death. Biochem Pharmacol (1968) 0.87
Plasmid curing and antibacterial effects of some chlorpromazine derivatives in relation to their molecule orbitals. Acta Microbiol Acad Sci Hung (1978) 0.81
Inhibition of human neutrophil chemotaxis in vitro by phenothiazines and related compounds. Infect Immun (1976) 0.81
Adverse effects of chlorpromazine on murine host-defense responses against infection with Candida albicans. J Infect Dis (1984) 0.81
Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet (1988) 3.50
Attributes of potential utility in differentiating among "group H" streptococci or Streptococcus sanguis. J Dent Res (1976) 2.17
Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine. Gut (1986) 1.83
Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition. J Immunol (1988) 1.70
Effect of influenza infection on the phagocytic and bactericidal activities of pulmonary macrophages. Infect Immun (1979) 1.48
The pathogenesis of pneumonitis due to murine cytomegalovirus. J Infect Dis (1982) 1.32
Soluble CD4 in patients with rheumatoid arthritis and osteoarthritis. Clin Immunol Immunopathol (1991) 1.25
Nonphagocytic clearance of Staphylococcus aureus from murine lungs. Infect Immun (1982) 1.23
Effects of sublethal concentrations of amphotericin B on Candida albicans. J Infect Dis (1986) 1.19
Bronchodilator testing: confidence intervals derived from placebo inhalations. Am Rev Respir Dis (1983) 1.18
Preparation of protoplasts of group H streptococci (Streptococcus sanguis). Appl Microbiol (1975) 1.11
Soluble CD8 in patients with rheumatic diseases. Clin Exp Immunol (1990) 1.09
In situ hybridisation. Ann Rheum Dis (1990) 1.04
Macrophage function in pulmonary alveolar proteinosis. Am Rev Respir Dis (1983) 1.00
Interleukin 1 in rheumatoid arthritis: potentiation of immune responses within the joint. Lymphokine Res (1989) 0.98
Invasive aspergillosis following post-influenzal pneumonia. Br J Dis Chest (1983) 0.96
Chronic glucocorticosteroid therapy impairs staphylococcal clearance from murine lungs. Infect Immun (1982) 0.96
Stimulated human alveolar macrophages secrete interferon. Am Rev Respir Dis (1985) 0.94
Tracheal function during influenza infections. Infect Immun (1983) 0.93
Cellular location of degradative enzymes in Staphylococcus aureus. J Bacteriol (1974) 0.93
Characterization of group H streptococcal temperate bacteriophage phi 227. J Virol (1977) 0.93
Staphylococcal clearance and pulmonary macrophage function during influenza infection. Infect Immun (1982) 0.92
Plasmodium knowlesi: morphology and course of infection in rhesus monkeys treated with clindamycin and its N-demethyl-4'-pentyl analog. Exp Parasitol (1976) 0.88
Uniformity of bronchoalveolar lavage in patients with pulmonary sarcoidosis. Am Rev Respir Dis (1988) 0.87
Pulmonary tissue resistance to Candida albicans in normal and in immunosuppressed mice. Am Rev Respir Dis (1983) 0.87
Inhibition of macrophage phagocytosis after contact with ingestible particles. J Reticuloendothel Soc (1981) 0.84
Plasma levels of interleukin-1-alpha in rheumatoid arthritis. Br J Rheumatol (1991) 0.84
Effect of Candida morphology on amphotericin B susceptibility. Antimicrob Agents Chemother (1987) 0.83
Pneumonia due to Histoplasma capsulatum in a bone marrow transplant recipient. Thorax (1987) 0.81
Candidacidal factors in murine bronchoalveolar lavage fluid. Infect Immun (1987) 0.81
Intralipid effects on reticuloendothelial function. J Leukoc Biol (1984) 0.81
Pseudomonas aeruginosa clearance in mice: comparison of tissue, strain, and corticosteroid effects. Infect Immun (1984) 0.80
Verapamil inhibits influenza A virus replication. Arch Virol (1984) 0.78
Cellular retinoic acid-binding protein in human lung carcinomas. J Natl Cancer Inst (1981) 0.78
Modulation of pulmonary clearance of bacteria by antioxidants. Infect Immun (1985) 0.77
Effect of alkylating agents on the clearance of Staphylococcus aureus from murine lungs. J Leukoc Biol (1987) 0.77
Immunologic hemorrhagic pneumonia caused by isocyanates. Am Rev Respir Dis (1990) 0.76
Cellular location of alpha-hemolysin in Staphylococcus aureus. Infect Immun (1975) 0.75
Flow volume loops in diagnosis. Chest (1990) 0.75
Pulmonary clearance of Candida albicans in neutropenic mice. J Infect Dis (1984) 0.75
Interaction between Candida agglutinins and antifungal agents. Mycopathologia (1987) 0.75
Effects of cyclosporine on pulmonary clearance of Staphylococcus aureus and Pseudomonas aeruginosa. J Infect Dis (1986) 0.75
Management of hepatic hydrothorax with a peritoneovenous (Denver) shunt. South Med J (1990) 0.75
Thoracic gas volume measurement. Increased variability in patients with obstructive ventilatory defects. Chest (1984) 0.75
Alveolar macrophage gold retention in rheumatoid arthritis. J Rheumatol (1987) 0.75